JIOMSN – Jain Institute of Movement Disorder & Stereotactic Neurosurgery

• Minimally Invasive Neurosurgery (MIN)
• Stereotactic and Functional Neurosurgery (SFNS)
• Stereotactic Radiosurgery (SRS)
• Treatment for Dystonia
• Treatment for Tremors
• Treatment for PD (Parkinson’s Disease)
• Treatment for Spasticity & Epilepsy

The INS (the International Neuromodulation Society) defines neuromodulation as a field of science, medicine, and bioengineering that encompasses implantable and non—implantable technologies, electrical or chemical, for the purpose of improving the quality of life and functioning of humans. Neuromodulation is “technology impacting on the neural interface.”Neuromodulation devices and treatments are life-changing. They affect every area of the body and treat a wide range of diseases or symptoms from headaches to tremors to spasticity to the spinal cord damage to urinary incontinence. With such a broad therapeutic scope and significant ongoing improvements in biotechnology, it is not surprising that neuromodulation is poised as a major therapy option in the next decade.

Movements disorders are clinical, pathologically & genetically a heterogeneous group of disease characterized by impairment of Planning, Control & Execution of moments.
There are two types:
1.HypoKinetic – Slowness of moment & Rigidity. Ex: Parkinson’s Disease

2.Hyperkinetic – Disorders with excessive moments or spontaneous. Ex: Dystonia, Chorea, Athetosis

• Tremors-dominant Parkinson’s Disease
• Essential Tremors
• Post MS (Multiple Sclerosis) Tremor
• Post-Stroke Tremor
• Post-Head Injury Tremor
• Dystonic Tremor

DYSTONIA

Dystonia is a movement disorder in which a person’s muscles contract uncontrollably. The contraction causes the affected body part to twist involuntarily in repetitive movements or abnormal postures. Dystonia can affect one muscle, a group of muscle or entire body

Parkinson’s Disease (PD) is the most common neurodegenerative cause of Parkinsonism, a clinical syndrome characterized by lesions in the basal ganglia, predominantly in the substantia nigra. PD makes up approximately 80% of cases of Parkinsonism. Levodopa is the mainstay in medical management. However, the
progression of the disease, combined with prolonged Levodopa use can result in some disabling motor symptoms.

Two types of Parkinson’s Disease:

• Tremor predominant
• Rigidity-bradykinesia predominant